Report Detail
Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2020-2026
- RnM4098709 |
- 14 July, 2020 |
- Global |
- 94 Pages |
- QYResearch |
- Service & Software
Artificial Intelligence Drug R&D market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence Drug R&D market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
AI Platfrom
Analytics Service
Market segment by Application, split into
Drug Discovery
Precision Medicine
Based on regional and country-level analysis, the Artificial Intelligence Drug R&D market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Artificial Intelligence Drug R&D market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
IBM Watson
BioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 AI Platfrom
- 1.2.3 Analytics Service
- 1.3 Market by Application
- 1.3.1 Global Artificial Intelligence Drug R&D Market Share by Application: 2020 VS 2026
- 1.3.2 Drug Discovery
- 1.3.3 Precision Medicine
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Artificial Intelligence Drug R&D Market Perspective (2015-2026)
- 2.2 Global Artificial Intelligence Drug R&D Growth Trends by Regions
- 2.2.1 Artificial Intelligence Drug R&D Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Artificial Intelligence Drug R&D Historic Market Share by Regions (2015-2020)
- 2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Artificial Intelligence Drug R&D Players by Market Size
- 3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2015-2020)
- 3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2015-2020)
- 3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
- 3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
- 3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2019
- 3.5 Key Players Artificial Intelligence Drug R&D Area Served
- 3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
- 3.7 Date of Enter into Artificial Intelligence Drug R&D Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence Drug R&D Breakdown Data by Type (2015-2026)
- 4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2015-2020)
- 4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2021-2026)
5 Artificial Intelligence Drug R&D Breakdown Data by Application (2015-2026)
- 5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2015-2020)
- 5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Artificial Intelligence Drug R&D Market Size (2015-2026)
- 6.2 North America Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
- 6.3 North America Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
- 6.4 North America Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Artificial Intelligence Drug R&D Market Size (2015-2026)
- 7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
- 7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
- 7.4 Europe Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Artificial Intelligence Drug R&D Market Size (2015-2026)
- 8.2 China Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
- 8.3 China Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
- 8.4 China Artificial Intelligence Drug R&D Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Artificial Intelligence Drug R&D Market Size (2015-2026)
- 9.2 Japan Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
- 9.3 Japan Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
- 9.4 Japan Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Artificial Intelligence Drug R&D Market Size (2015-2026)
- 10.2 Southeast Asia Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
- 10.3 Southeast Asia Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
- 10.4 Southeast Asia Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 IBM Watson
- 11.1.1 IBM Watson Company Details
- 11.1.2 IBM Watson Business Overview
- 11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
- 11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2015-2020))
- 11.1.5 IBM Watson Recent Development
- 11.2 BioXel
- 11.2.1 BioXel Company Details
- 11.2.2 BioXel Business Overview
- 11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
- 11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.2.5 BioXel Recent Development
- 11.3 Insilico Medicine
- 11.3.1 Insilico Medicine Company Details
- 11.3.2 Insilico Medicine Business Overview
- 11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
- 11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.3.5 Insilico Medicine Recent Development
- 11.4 Gatehouse Bio
- 11.4.1 Gatehouse Bio Company Details
- 11.4.2 Gatehouse Bio Business Overview
- 11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
- 11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.4.5 Gatehouse Bio Recent Development
- 11.5 Google DeepMind
- 11.5.1 Google DeepMind Company Details
- 11.5.2 Google DeepMind Business Overview
- 11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
- 11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.5.5 Google DeepMind Recent Development
- 11.6 Genpact Cora
- 11.6.1 Genpact Cora Company Details
- 11.6.2 Genpact Cora Business Overview
- 11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
- 11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.6.5 Genpact Cora Recent Development
- 11.7 Cyclica Inc
- 11.7.1 Cyclica Inc Company Details
- 11.7.2 Cyclica Inc Business Overview
- 11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
- 11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.7.5 Cyclica Inc Recent Development
- 11.8 QuantumBlack
- 11.8.1 QuantumBlack Company Details
- 11.8.2 QuantumBlack Business Overview
- 11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
- 11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.8.5 QuantumBlack Recent Development
- 11.9 Nq Medical
- 11.9.1 Nq Medical Company Details
- 11.9.2 Nq Medical Business Overview
- 11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
- 11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.9.5 Nq Medical Recent Development
- 11.10 Phenomic AI
- 11.10.1 Phenomic AI Company Details
- 11.10.2 Phenomic AI Business Overview
- 11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
- 11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 11.10.5 Phenomic AI Recent Development
- 11.11 Palantir Technologies
- 10.11.1 Palantir Technologies Company Details
- 10.11.2 Palantir Technologies Business Overview
- 10.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
- 10.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
- 10.11.5 Palantir Technologies Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Artificial Intelligence Drug R&D. Industry analysis & Market Report on Artificial Intelligence Drug R&D is a syndicated market report, published as Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Artificial Intelligence Drug R&D market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
